GRANTS
Last Updated: August 2025
A First-in-class, Fully TPP-compliant Rapid Diagnostic Test for Trachoma Surveillance: Delivering the Missing Piece in WHO’s Worldwide Trachoma Elimination Efforts (GHIT Fund, 7 November 2024): https://www.ghitfund.org/investment/portfoliodetail/detail/223/en
In Support of WHO Schistosomiasis Control and Elimination Programs: Progressing a TPP-compliant serological test for Schistosoma mansoni to Field Testing and Manufacturing Process Development (GHIT Fund, 18 March 2025): https://www.ghitfund.org/investment/portfoliodetail/detail/235/en
First-in-class, highly sensitive and specific rapid diagnostic test to detect Paragonimus infections (National Institute of Allergy and Infectious Diseases).
1R43AI172459-01 (Phase I SBIR grant, 14 September 2022): https://reporter.nih.gov/search/OwkRYi0_bEGsGOoHG1bzlA/project-details/10545410#similar-Projects
Ultrasensitive, High-Specificity Rapid Test to Support the End-Game of the Global Program to Eliminate Lymphatic Filariasis (National Institute of Allergy and Infectious Diseases).
1. 1R44AI170131-01 (Year 1 of Phase I/II Fast Track SBIR grant, 15 April 2022): https://reporter.nih.gov/search/OwkRYi0_bEGsGOoHG1bzlA/project-details/10480110#similar-Projects
2. 1R44AI170131-02 (Year 2 of Phase I/II Fast Track SBIR grant, 12 July 2024): https://reporter.nih.gov/search/OwkRYi0_bEGsGOoHG1bzlA/project-details/11083346#similar-Projects
3. 1R44AI170131-03 (Year 3 of Phase I/II Fast Track SBIR grant): grant renewal currently under review.
Supporting WHO Onchocerciasis Elimination Programs: Progressing a Highly Sensitive and Ultra-Specific Rapid Diagnostic Test to Commercialization Readiness (National Institute of Allergy and Infectious Diseases).
1. 1R44AI174495-01A1 (Year 1 of Direct-to-Phase II SBIR grant, 16 March 2023): https://reporter.nih.gov/search/OwkRYi0_bEGsGOoHG1bzlA/project-details/10697164#similar-Projects
2. 5R44AI174495-02 (Year 2 of Direct-to-Phase II SBIR grant, 07 March 2024): https://reporter.nih.gov/search/OwkRYi0_bEGsGOoHG1bzlA/project-details/10810633
Supporting WHO Lymphatic Filariasis Elimination Programs: Progressing a Highly Sensitive and Specific Rapid Diagnostic Test for Brugia Species Infection to Commercialization Readiness (National Institute of Allergy and Infectious Diseases).
1. 1R44AI184015-01 (Year 1 of Direct-to-Phase II, 25 April 2024): https://reporter.nih.gov/search/OwkRYi0_bEGsGOoHG1bzlA/project-details/10919722#similar-Projects
2. 1R44AI184015-02 (Year 2 of Direct-to-Phase II SBIR grant): https://reporter.nih.gov/search/M9Tp3sE41kypYHNdphKuKA/project-details/11079584#similar-Projects
An Easy-to-Use, Low-Cost Triplex RDT for the Simultaneous Diagnosis of HBV, HCV, AND HIV Infection, Compatible with Field Use in LMICS and At-Home Use in the US (National Institute of Allergy and Infectious Diseases).
75N93024C00025-0-9999-1 (Phase I contract, FY2024): https://reporter.nih.gov/search/OwkRYi0_bEGsGOoHG1bzlA/project-details/11170172#similar-Projects
Novel diagnostic biomarkers discovery and validation for select neglected tropical diseases (National Institute of Allergy and Infectious Diseases).
75N93025C00005-0-9999-1 (Phase I contract, FY2025): https://reporter.nih.gov/search/OwkRYi0_bEGsGOoHG1bzlA/project-details/11306897#similar-Projects